UBS O'Connor’s Immunomedics Inc IMMU Stock Holding History

UBS O'Connor’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,392,226	Closed	-$118M	–	679
2020 Q3	$118M	Buy	+1,392,226	New	+$70.4M	3.01%	6
2018 Q3	–	Sell	-100,000	Closed	-$2.37M	–	349
2018 Q2	$2.37M	Buy	+100,000	New	+$2.01M	0.05%	153

UBS O'Connor's IMMU Position: Q4 2020 in Review

UBS O'Connor sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,392,226 shares — an estimated $118M sold.

UBS O'Connor first reported a position in IMMU in Q2 2018 and held it in 2 quarters. The position peaked at $118M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

UBS O'Connor reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
UBS O'Connor sold 1,392,226 Immunomedics Inc shares in Q4 2020, an estimated $118M.
UBS O'Connor first reported a position in Immunomedics Inc in Q2 2018 and held it in 2 quarters.
UBS O'Connor's Immunomedics Inc position peaked at $118M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on UBS O'Connor's 13F filing for Q4 2020, filed 17 Feb 2021.